Fractyl Health Virtual Commercial Day: The Path to Commercializing Revita®, the Potential First Procedural Therapy for Post-GLP-1 Weight Maintenance
Sep 1, 2026 | 11:00 AM EDT
Investor Relations Contacts
Brian Luque, Head of Investor Relations and Corporate Development
Email: ir@fractyl.com
Phone: 951.206.1200